Best Healthcare Companies in Boulder, United States
The 68 best Healthcare companies in Boulder, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: LightDeck Diagnostics.
Ranked: Best Healthcare companies in Boulder
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LightDeck Diagnostics Developer of point-of-care diagnostic device for multiplex assays | $56M | 48 mo ago | Acquired | 80 | 2009 | Nick Traggis CEO | — | — |
| 2 | Pharmion Therapies for the treatment of hematology and oncology disorders | $40M | 284 mo ago | Acquired | — | 2000 | Patrick J. Mahaffy Ex - CEO and Founder | 33 patents Synthesis, crystallization, and formulation of 5‑azacytidine nucleoside drug | — |
| 3 | Bolder BioTechnology Advanced protein engineering for effective, easy-to-use protein therapeutics to improve lives | $31M | 28 mo ago | Funding Raised | — | 1997 | George Cox Founder & President | 124 patents Enhancing tumor immunogenicity, radioprotective hematopoietic factors, and stem‑cell immunomodulation therapies. | — |
| 4 | Yasso Developer of probiotics, frozen greek yogurt bars and candy bars | $15M | 113 mo ago | Acquired | 42 | 2009 | — | — | — |
| 5 | BackJoy Manufacturer of posture support seats and related products | $11M | 117 mo ago | Series A | 110 | 2005 | Bing Howenstein Founder & CEO | — | — |
| 6 | Next Frontier Biosciences Breeding technology research for medical cannabis industry | $9M | 77 mo ago | Deadpooled | 4 | 2014 | — | — | — |
| 7 | New Iridium Manufacturer of phenoxazine and dihydrophenazine 24Talent top 28%Funding top 39%Global bottom 29%Market bottom 19% All 4 signals ▾Talenttop 28% Fundingtop 39% Globalbottom 29% Marketbottom 19% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $6.1M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $6M | 12 mo ago | Seed | 11 | 2016 | Garrett Miyake Co-Founder & CTO | — | — |
| 8 | Lazzaro Medical Developer of medical device designed for restoring healthy breathing | $6M | 24 mo ago | Series A | 2 | 2019 | Robert Israel Co-Founder & CEO | — | — |
| 9 | Encision Laparoscopic surgical instruments improving patient safety and surgical outcomes 32Funding top 39%Patents top 39%Innovation top 45%News top 47% All 10 signals ▾Fundingtop 39% Patentstop 39% Innovationtop 45% Newstop 47% Techbottom 46% Fin. healthbottom 40% Marketbottom 39% Growthbottom 37% Globalbottom 35% Moatbottom 35% Funding: Raised $5.1M across 4 rounds · 4 rounds over 14 yrs (0.3/yr) Patents: 51 patents matched (strict assignee match) · 7 filings since 2022 vs 11 in 2017-21 rank vs industry peers · Fliar Intelligence Index 32/100 | $5M | 10 mo ago | Public | 24 24 → 38 (+58%) | 1991 | — | 50 patents Monitoring and fault detection for electrosurgical instrument distal ends and shields | — |
| 10 | Quality Biomedical Provider of medical equipment repair and maintenance services | $5M | 81 mo ago | Series A | 100 | 2017 | — | — | — |
| 11 | Brava Diagnostics Developer of point-of-care tests for acute care | $4M | 78 mo ago | Deadpooled | — | 2018 | Byron Hewett Founder & CEO | — | — |
| 12 | Weller Brand of coconut bites | $4M | 83 mo ago | Seed | 8 | 2017 | John Simmons Co-Founder | — | — |
| 13 | LucidMood Retailer of cannabis products | $4M | 89 mo ago | Series A | 2 | 2015 | Charles M. Jones Founder & CEO | — | — |
| 14 | Chooze Corp Brand of cannabis medical, nutritional, and other products | $4M | 89 mo ago | Series A | — | 2016 | Dave Georges CEO | — | — |
| 15 | Green Dot Labs Produces and supplies cannabis products | $3M | 105 mo ago | Series A | 27 | 2013 | Dave Malone Co-Founder | — | — |
| 16 | Althea Provider of psychedelic therapy facilitator matching services | $2M | 7 mo ago | Seed | — | 2024 | Sara Bates Co-Founder & CPO | 64 patents Protein crystal engineering for biopharma enzymes and therapeutic protein formulations | — |
| 17 | Play Health Developer of clinical decision support software for perimenopause and menopause | $500K | 8 mo ago | Seed | — | — | Andrea Mazzocchi Co-Founder & CEO | — | — |
| 18 | Seedling Biosystems Provider of essential ingredients for infant formulas | $350K | 9 mo ago | Seed | — | 2020 | Brian DeDecker Co-Founder & CEO | — | — |
| 19 | TissueForm Manufacturer of dermal fillers | $275K | 21 mo ago | Funding Raised | 3 | 2019 | Jeanne Barthold Co-Founder | — | 1 award |
| 20 | Boulder Sterilization Provider of sterilization services for medical devices manufacturing companies | $250K | 61 mo ago | Funding Raised | — | 2019 | Jim Kasic Founder & CEO | — | — |
| 21 | Everscore Offers CBD products and retail services | $150K | 53 mo ago | Series A | 6 | 2019 | — | — | — |
| 22 | StrideTech Provider of smart walker devices to improve senior mobility and prevent falls | $100K | 67 mo ago | Seed | 7 | 2019 | Humsini Acharya Co-Founder | — | — |
Top 12 Healthcare companies in Boulder
#1
Public · Boulder, Colorado · founded 1991 · 24 employees$5.1Mraised▾
Laparoscopic surgical instruments improving patient safety and surgical outcomes. They specialize in advanced energy electrosurgical solutions designed to minimize patient burns during minimally invasive surgery. Their AEM Shield technology enhances safety in laparoscopic procedures. They offer a range of laparoscopic instruments and reposable scissors, focusing on improving clinical performance and reducing operational expenses. They provide continuing education for clinicians and support for their products. They are committed to innovation and patient well-being in the surgical field. Their products directly impact patient safety and surgical outcomes.
- Aug 2025Post IPO$500K
- Jan 2019Post IPO$875K
- Jan 2014Post IPO$2M
- Apr 2012Post IPO$1.8M
#2
Seed · Boulder, Colorado · founded 2024$2.5Mraised▾
Provider of psychedelic therapy facilitator matching services. It connects individuals seeking psilocybin therapy with licensed facilitators. The service includes a questionnaire to match clients with appropriate facilitators based on individual needs and preferences. Preparation for the therapy journey, including medical screening and intention-setting, is facilitated. Financial assistance is also offered through a dedicated fund. Educational resources and articles on psychedelic therapy are provided to support clients and increase understanding of the process.
- Oct 2025Seed$1M
- Jul 2024Seed$1.5M
#3
Seed · Boulder, Colorado · founded 2016 · 11 employees$6.1Mraised▾
Manufacturer of phenoxazine and dihydrophenazine
- Jun 2025Seed$2.6M
- Jul 2024Grant (prize money)$200K
- Jun 2023Grant (prize money)$1M
- May 2020Grant (prize money)$256K
#4
Seed · Boulder, Colorado$500Kraised▾
Developer of clinical decision support software for perimenopause and menopause. The software facilitates care through individual, comprehensive health data for clinicians. It captures patient symptoms, which are often missed in today’s care model. The software brings experience and clinical context together, enabling better conversations and data-informed decisions. The software prioritizes data quality, longitudinal insight, and clinical relevance.
- Sep 2025Seed$500K
#5
Seed · Boulder, Colorado · founded 2020$350Kraised▾
Provider of essential ingredients for infant formulas
- Sep 2025Grant (prize money)$179.1K
- Feb 2024Seed$150K
- Dec 2023Seed$200K
#6
Funding Raised · Boulder, Colorado · founded 1997$31.2Mraised▾
Advanced protein engineering for effective, easy-to-use protein therapeutics to improve lives. This is a biotechnology company focused on empowering proteins to better treat diseases. It develops cost-effective, easy-to-use protein therapeutics with a diversified product pipeline including treatments for hematological and endocrine disorders, cancer, and infectious diseases. The company utilizes protein engineering technologies to create proprietary products, increasing a protein's effective size and slowing its clearance from the body. They aim to commercialize products independently and through strategic alliances. The company is also involved in biodefense, supporting the development of drugs to prevent or treat complications of acute, high-dose radiation exposure.
- Feb 2024Grant (prize money)$295.9K
- Jul 2021Grant (prize money)$300K
- Jul 2019Grant (prize money)$2.3M
- Mar 2013Grant (prize money)$3.2M
#7
Series A · Boulder, Colorado · founded 2019 · 2 employees$5.9Mraised▾
Developer of medical device designed for restoring healthy breathing
- Jun 2024Grant (prize money)$1.3M
- Oct 2022Grant (prize money)$250K
- Oct 2022Series A$1M
- Feb 2022Series A$4.9M
#8
Acquired · Boulder, Colorado · founded 2009 · 80 employees$56.4Mraised▾
Developer of point-of-care diagnostic device for multiplex assays. The company's proprietary LightDeck platform combines an advanced laser waveguide with novel materials and manufacturing techniques to deliver a portfolio of in vitro diagnostic panels. Its flagship product is the MBio Array System that uses disposable cartridges to allow fluorescence immunoassays to be run automatically and simultaneously.
- Jun 2022Grant (prize money)—
- Mar 2022Series B$6.1M
- Mar 2021Series B$1.7M
- Feb 2021Series B$10M
#9
Funding Raised · Boulder, Colorado · founded 2019 · 3 employees$274.8Kraised▾
Developer of microparticle tissue technology designed to treat patients suffering from tissue disease, damage, or aging. The company's technology uses dermal fillers that are bio stimulatory, natural, and long-lasting, enabling patients to save time and improve their outcomes while also increasing the profitability of small private plastic surgery clinics.
- Sep 2024Grant (prize money)$274.8K
#10
Acquired · Boulder, Colorado · founded 2000$40Mraised▾
Pharmion was focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology disorders. It had a number of products on the market including the first approved epigenetic cancer drug, Vidaza, a DNA demethylating agent. Its other marketed portfolio products include Thalidomide Pharmion for the treatment of relapsed and refractory multiple myeloma; Innohep, an antithrombotic drug in the heparin group and Refludan, an anticoagulant that functions as a direct thrombin inhibitor. Pharmion was acquired by Celgene in November 2007 for $2.9B.
- Oct 2002Series A$40M
- Dec 2001Conventional Debt$65M
#11
Deadpooled · Boulder, Colorado · founded 2014 · 4 employees$8.7Mraised▾
Next Frontier Bio is a biotechnology company involved in the research and development related to breeding technology and processing of medical cannabis for the subsequent development of medicinal products. The company claims that it has formulated cannabinoid products that provide various benefits in the research as well as in the development of novel medicinal products for patients.
- Jan 2020Series A$825.6K
- Jan 2019Series A$2.9M
- May 2017Seed$1.8M
- Oct 2016Seed$850K
#12
Acquired · Boulder, Colorado · founded 2009 · 42 employees$15.1Mraised▾
Yasso is a manufacturer of probiotics based frozen Greek yogurt bars and candy bars. The company claims to offer 13 flavors in frozen bars, and 2 flavours in the candy bars category. It also claims that the products are all-natural including real Greek yogurt, rBST-free milk, and natural sweeteners. The products are available across multiple retail channels such as Walmart, Costco and others.
- Jan 2017Series B—
- Aug 2015Series B$6.1M
- Dec 2014Series B$2.5M
- Nov 2013Series A$4M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.